Skip to main content

Short-term efficacy of topical capsaicin therapy in severely affected fibromyalgia patients

Rheumatology International volume 33, pages 2665–2670 (2013)Cite this article

Abstract

The purpose of this study was to evaluate the short-term efficacy of topical capsaicin treatment in patients severely affected by fibromyalgia. One hundred and thirty fibromyalgia patients were randomly divided into two groups. The control group, 56 women and 4 men who continued their medical treatment, and the capsaicin group, 70 women who apart from continuing their medical treatment, also underwent topical capsaicin 0.075 % 3 times daily for 6 weeks. At the beginning of the program, there were no significant differences between the two groups in any of the analyzed parameters. At the end of the treatment, there were significant improvements in the capsaicin group in the myalgic score (5.21 vs 3.8, p = 0.02) and global subjective improvement (22.8 vs 5 %, p = 0.001). Six weeks after the end of the treatment, the experimental group showed significant differences in Visual Analogue Scale of depression (5.63 vs 7.35, p = 0.02), Fibromyalgia Impact Questionnaire (67.89 vs 77.7, p = 0.02), role limitations due to emotional problems (36.17 vs 17.2, p = 0.05), Fatigue Severity Scale (6.2 vs 6.6, p = 0.04), myalgic score (3.94 vs 2.66, p = 0.02) and pressure pain threshold (79.25 vs 56.71, p = 0.004). In conclusion, patients severely affected by fibromyalgia can obtain short-term improvements following topical capsaicin 0.075 % treatment three times daily for 6 weeks.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of FM: report of the Multicenter Criteria Committee. Arthritis Rheum 33(2):160–172

    Article  PubMed  CAS  Google Scholar 

  2. Staud R (2002) Evidence of involvement of central neural mechanisms in generating fibromyalgia pain (review). Curr Rheumatol Rep 4(4):299–305

    Article  PubMed  Google Scholar 

  3. Herpfer I, Lieb K (2003) Substance P and substance P receptor antagonists in the pathogenesis and treatment of affective disorders. World J Biol Psychiatry 4(2):56–63

    Article  PubMed  Google Scholar 

  4. Russell IJ, Orr MD, Littman B et al (1994) Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 37(11):1593–1601

    Article  PubMed  CAS  Google Scholar 

  5. Nolano M, Simone DA, Wendelschafer-Crabb G et al (1999) Topical capsaicin in humans: parallel loss of epidermal nerve fibres and pain sensation. Pain 81(1–2):135–145

    Article  PubMed  CAS  Google Scholar 

  6. Morgenlander JC, Hurwitz BJ, Massey EW (1990) Capsaicin for the treatment of pain in Guillain-Barré syndrome. Ann Neurol 28(2):199

    Article  PubMed  CAS  Google Scholar 

  7. Mason L, Moore RA, Derry S et al (2004) Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 328(7446):991

    Article  PubMed  CAS  Google Scholar 

  8. Vargas A, Vargas A, Hernandez-Paz R et al (2006) Sphygmomanometry-evoked allodynia-a simple bedside test indicative of fibromyalgia: a multicentre developmental study. J Clin Rheumatol 12(6):272–274

    Article  PubMed  Google Scholar 

  9. Lázaro C, Bosch F, Torrubia R et al (1994) The development of a Spanish questionnaire for assessing pain: preliminary data concerning reliability and validity. Eur J Psychol Assess 10(2):145–151

    Google Scholar 

  10. Tan G, Jensen MP, Thornby JI et al (2004) Validation of the brief pain inventory for chronic nonmalignant pain. J Pain 5(2):133–137

    Article  PubMed  Google Scholar 

  11. Krupp LB, LaRocca NG, Muir-Nash J et al (1989) The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1124

    Article  PubMed  CAS  Google Scholar 

  12. Royuela Rico A, Macías Fernández JA (1997) Propiedades clinimétricas de la versión castellana del cuestionario de Pittsburgh. Vigilia-Sueño 9(2):81–94

    Google Scholar 

  13. Beck AT, Brown G, Epstein N et al (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consul Clin Psychol 56:893–897

    Article  CAS  Google Scholar 

  14. Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571

    Article  PubMed  CAS  Google Scholar 

  15. García Campayo J, Rodero B, Alda M et al (2008) Validation of the Spanish version of the Pain Catastrophizing Scale in fibromyalgia. Med Clín 131(13):487–492

    Article  Google Scholar 

  16. Rivera J, Gonzalez T (2004) The Fibromyalgia impact questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol 22(5):554–560

    PubMed  CAS  Google Scholar 

  17. Bruce B, Fries JF (2003) The Stanford health assessment questionnaire: dimensions and practical applications. Health Qual Life Outcomes 1(1):20

    Article  PubMed  Google Scholar 

  18. Harwood RH, Rogers A, Dickinson E et al (1994) Measuring handicap: the London handicap scale a new outcome measure for chronic disease. Qual Health Care 3(1):11–16

    Article  PubMed  CAS  Google Scholar 

  19. Staud R (2010) Is it all central sensitization? Role of peripheral tissue nociception in chronic musculoskeletal pain. Cur Rheumatol Rep 12(6):448–454

    Article  Google Scholar 

  20. Hong CZ, Hsueh TC (1996) Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia. Arch Phys Med Rehabil 77(11):1161–1166

    Article  PubMed  CAS  Google Scholar 

  21. Morris V, Cruwys S, Kidd B (1998) Increased capsaicin-induced secondary hyperalgesia as a marker of abnormal sensory activity in patients with fibromyalgia. Neurosci Lett 250(3):205–207

    Article  PubMed  CAS  Google Scholar 

  22. McCarty DJ, Csuka M, McCarthy G et al (1994) Treatment of pain due to fibromyalgia with topical capsaicin: a pilot study. Semin Arthritis Rheum 23(Suppl 3):41–47

    Article  Google Scholar 

  23. Acasuso Diaz M, Collantes Estevez E, Jordi Reus S (1998) Capsaicina versus ketoprofen en tratamiento tópico de la fibromialgia primaria. XXIV Congreso Nacional de la Sociedad Española de Reumatología, Cádiz, Junio

    Google Scholar 

  24. Ebner K, Muigg P, Singewald G et al (2008) Substance P in stress and anxiety: NK-1 receptor antagonism interacts with key brain areas of the stress circuitry. Ann NY Acad Sci 1144:61–73

    Article  PubMed  CAS  Google Scholar 

  25. Wallace DJ, Linker-Israeli M, Hallegua D et al (2001) Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology (Oxford) 40(7):743–749

    Article  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Rheumatology Service at the Specialist Clinic of Cantabria, Santander, Spain

    Benigno Casanueva

  2. Rodero Center, Santander, Spain

    Baltasar Rodero

  3. Neurophysiology Service, Santa Clotilde Hospital, Santander, Spain

    Covadonga Quintial

  4. Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, IFIMAV, Santander, Spain

    Javier Llorca

  5. Rheumatology Service, Hospital Universitario Marqués de Valdecilla. IFIMAV, Avenida Valdecilla 25, 39008, Santander, Cantabria, Spain

    Miguel A. González-Gay

Authors
  1. Benigno Casanueva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Baltasar Rodero
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Covadonga Quintial
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Javier Llorca
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Miguel A. González-Gay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Miguel A. González-Gay.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Casanueva, B., Rodero, B., Quintial, C. et al. Short-term efficacy of topical capsaicin therapy in severely affected fibromyalgia patients. Rheumatol Int 33, 2665–2670 (2013). https://doi.org/10.1007/s00296-012-2490-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-012-2490-5

Keywords

  • Fibromyalgia
  • Capsaicin therapy
  • Chronic pain
  • Clinical assessment